Program Overview:

Esteemed panelists from around the world will discuss practical management strategies, evolving evidence, and “real-world” decision-making within the burgeoning field of molecular otology.

Distinguished Panelists:

• Carleton Eduardo Corrales, MD
  Harvard Medical School; Brigham and Women’s Hospital, Boston, Massachusetts, United States
  Regeneron Trial Results, DBOTO Findings & Surgical Innovation
• Hubert Löwenheim, MD, PhD
  University of Tübingen - The University Hospital, Tübingen, Germany
  The Road Here: From Friedrich Miescher to Clinical Trials
• Lawrence R. Lustig, MD
  Columbia University Medical Center, New York, New York, United States
  Building the Bridge: The Preclinical Mouse Data and the Path to the Clinic
• Yilai Shu, MD, PhD
  Eye & ENT Hospital of Fudan University, Shanghai, China
  International Expert Consensus on Gene Therapy for Hereditary Hearing Loss: Based on Clinical Trials

Moderators:

• Soha Ghossaini, MD
  Intent Medical Group Endeavor Health Advanced Neurosciences Center, Chicago, Illinois, United States
• Hernan Goldsztein, MD
  Pacific ENT Medical Group, San Diego, California, United States

The AAO-HNSF Global Grand Rounds series is an initiative of the Academy’s International Advisory Board (IAB) to improve care of patients and physician education around the globe. Virtual events are held quarterly, and are open to all otolaryngologists around the world, free of charge.

For more information about the Global Grand Rounds series, visit www.entnet.org/GGR.